Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.


Results 1-8 of 8 (Search time: 0.002 seconds).
  • previous
  • 1
  • next
Item hits:
PreviewIssue DateTitleAuthor(s)
2002Calcitonin decreases the adherence and survival of HEK-293 cells by a caspase-independent mechanismFindlay, D.; Raggatt, L.; Bouralexis, S.; Hay, S.; Atkins, G.; Evdokiou, A.
1999Calcitonin Receptor-Mediated Growth Suppression of HEK-293 Cells is Accompanied by Induction of p21 WAF1/CIP1 and G2/M ArrestEvdokiou, A.; Raggatt, L.; Findlay, D.; Atkins, G.
2011Anticancer efficacy of Apo2L/TRAIL is retained in the presence of high and biologically active concentrations of osteoprotegerin in vivoZinonos, I.; Labrinidis, A.; Lee, M.; Liapis, V.; Hay, S.; Ponomarev, V.; Diamond, P.; Findlay, D.; Zannettino, A.; Evdokiou, A.
2002Human osteoblasts are resistant to Apo2L/TRAIL-mediated apoptosisAtkins, G.; Bouralexis, S.; Evdokiou, A.; Hay, S.; Labrinidis, A.; Zannettino, A.; Haynes, D.; Findlay, D.
2000Intracellular zinc depletion induces caspase activation and p21Waf1/Cip1 cleavage in human epithelial cell linesChai, F.; TruongTran, A.; Evdokiou, A.; Young, G.; Zalewski, P.
2003Induction of cell death of human osteogenic sarcoma cells by zoledronic acid resembles anoikisEvdokiou, A.; Labrinidis, A.; Bouralexis, S.; Hay, S.; Findlay, D.
2009Apomab, a fully human agonistic antibody to DR5, exhibits potent antitumor activity against primary and metastatic breast cancerZinonos, I.; Labrinidis, A.; Lee, M.; Liapis, V.; Hay, S.; Ponomarev, V.; Diamond, P.; Zannettino, A.; Findlay, D.; Evdokiou, A.
2009Zoledronic acid inhibits both the osteolytic and osteoblastic components of osteosarcoma lesions in a mouse modelLabrinidis, A.; Hay, S.; Liapis, V.; Ponomarev, V.; Findlay, D.; Evdokiou, A.